Apyx Medical Corporation (APYX)
USD 1.16
(-5.69%)
USD 1.16
(-5.69%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -18.71 Million USD | 19.61% |
| 2022 | -23.27 Million USD | -53.14% |
| 2021 | -15.2 Million USD | -27.67% |
| 2020 | -11.9 Million USD | 39.41% |
| 2019 | -19.65 Million USD | -130.7% |
| 2018 | 64 Million USD | 1364.5% |
| 2017 | -5.06 Million USD | -28.15% |
| 2016 | -3.95 Million USD | 26.44% |
| 2015 | -5.37 Million USD | 68.93% |
| 2014 | -17.28 Million USD | -298.29% |
| 2013 | -4.33 Million USD | -803.24% |
| 2012 | 617 Thousand USD | 466.06% |
| 2011 | 109 Thousand USD | 107.1% |
| 2010 | -1.53 Million USD | -357.76% |
| 2009 | 595.52 Thousand USD | -67.49% |
| 2008 | 1.83 Million USD | -23.69% |
| 2007 | 2.4 Million USD | -10.53% |
| 2006 | 2.68 Million USD | 560.55% |
| 2005 | 406.2 Thousand USD | -73.13% |
| 2004 | 1.51 Million USD | 121.92% |
| 2003 | 681.31 Thousand USD | 232.35% |
| 2002 | -514.76 Thousand USD | -165.63% |
| 2001 | 784.29 Thousand USD | 56.66% |
| 2000 | 500.62 Thousand USD | 122.92% |
| 1999 | -2.18 Million USD | -118.81% |
| 1998 | -998.04 Thousand USD | -1106.19% |
| 1997 | 99.19 Thousand USD | -75.65% |
| 1996 | 407.3 Thousand USD | 364.31% |
| 1995 | -154.1 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -6.55 Million USD | 13.46% |
| 2024 Q1 | -7.57 Million USD | 21.14% |
| 2023 FY | -18.71 Million USD | 19.61% |
| 2023 Q1 | -3.53 Million USD | 41.76% |
| 2023 Q4 | -9.6 Million USD | -107.54% |
| 2023 Q3 | -4.62 Million USD | -365.69% |
| 2023 Q2 | -994 Thousand USD | 71.86% |
| 2022 Q3 | -5.79 Million USD | -6.33% |
| 2022 FY | -23.27 Million USD | -53.14% |
| 2022 Q4 | -6.06 Million USD | -4.66% |
| 2022 Q2 | -5.45 Million USD | 8.68% |
| 2022 Q1 | -5.96 Million USD | -197.95% |
| 2021 Q4 | -2 Million USD | 52.56% |
| 2021 FY | -15.2 Million USD | -27.67% |
| 2021 Q1 | -4.9 Million USD | -220.96% |
| 2021 Q2 | -4.04 Million USD | 17.45% |
| 2021 Q3 | -4.22 Million USD | -4.35% |
| 2020 FY | -11.9 Million USD | 39.41% |
| 2020 Q3 | -3.72 Million USD | 20.51% |
| 2020 Q2 | -4.69 Million USD | -140.39% |
| 2020 Q1 | -1.95 Million USD | 64.09% |
| 2020 Q4 | -1.52 Million USD | 59.04% |
| 2019 Q1 | -4.68 Million USD | -18.27% |
| 2019 FY | -19.65 Million USD | -130.7% |
| 2019 Q4 | -5.43 Million USD | -26.03% |
| 2019 Q3 | -4.31 Million USD | 0.62% |
| 2019 Q2 | -4.33 Million USD | 7.33% |
| 2018 Q1 | -935 Thousand USD | -13.47% |
| 2018 Q3 | 69.17 Million USD | 25531.62% |
| 2018 Q4 | -3.95 Million USD | -105.72% |
| 2018 FY | 64 Million USD | 1364.5% |
| 2018 Q2 | -272 Thousand USD | 70.91% |
| 2017 Q3 | -1.24 Million USD | 4.82% |
| 2017 FY | -5.06 Million USD | -28.15% |
| 2017 Q2 | -1.3 Million USD | 22.37% |
| 2017 Q1 | -1.68 Million USD | -222.18% |
| 2017 Q4 | -824 Thousand USD | 33.82% |
| 2016 Q4 | -523 Thousand USD | 45.75% |
| 2016 Q3 | -964 Thousand USD | -85.74% |
| 2016 Q2 | -519 Thousand USD | 73.3% |
| 2016 Q1 | -1.94 Million USD | -37.87% |
| 2016 FY | -3.95 Million USD | 26.44% |
| 2015 FY | -5.37 Million USD | 68.93% |
| 2015 Q4 | -1.41 Million USD | 11.15% |
| 2015 Q3 | -1.58 Million USD | -6.01% |
| 2015 Q2 | -1.49 Million USD | -70.89% |
| 2015 Q1 | -876 Thousand USD | 83.12% |
| 2014 Q2 | 251 Thousand USD | 102.61% |
| 2014 Q1 | -9.6 Million USD | -289.1% |
| 2014 Q3 | -2.73 Million USD | -1189.24% |
| 2014 FY | -17.28 Million USD | -298.29% |
| 2014 Q4 | -5.19 Million USD | -89.83% |
| 2013 Q3 | -341 Thousand USD | 69.53% |
| 2013 FY | -4.33 Million USD | -803.24% |
| 2013 Q4 | -2.46 Million USD | -624.05% |
| 2013 Q2 | -1.11 Million USD | -173.59% |
| 2013 Q1 | -409 Thousand USD | -243.01% |
| 2012 Q2 | 152 Thousand USD | -18.72% |
| 2012 Q3 | -7000.00 USD | -104.61% |
| 2012 FY | 617 Thousand USD | 466.06% |
| 2012 Q4 | 286 Thousand USD | 4185.71% |
| 2012 Q1 | 187 Thousand USD | 121.37% |
| 2011 Q4 | -875 Thousand USD | -1488.89% |
| 2011 Q3 | 63 Thousand USD | -85.31% |
| 2011 Q1 | 492 Thousand USD | 135.93% |
| 2011 Q2 | 429 Thousand USD | -12.8% |
| 2011 FY | 109 Thousand USD | 107.1% |
| 2010 FY | -1.53 Million USD | -357.76% |
| 2010 Q3 | 4236.00 USD | -92.4% |
| 2010 Q4 | -1.36 Million USD | -32423.56% |
| 2010 Q2 | 55.76 Thousand USD | 124.7% |
| 2010 Q1 | -225.77 Thousand USD | -924.41% |
| 2009 Q1 | 403.26 Thousand USD | 940.23% |
| 2009 Q4 | 27.38 Thousand USD | 172.55% |
| 2009 Q3 | -37.74 Thousand USD | -118.27% |
| 2009 Q2 | 206.67 Thousand USD | -48.75% |
| 2009 FY | 595.52 Thousand USD | -67.49% |
| 2008 Q4 | 38.76 Thousand USD | -89.4% |
| 2008 Q2 | 1.43 Million USD | 650.99% |
| 2008 Q1 | 190.44 Thousand USD | -32.17% |
| 2008 FY | 1.83 Million USD | -23.69% |
| 2008 Q3 | 365.89 Thousand USD | -74.42% |
| 2007 Q1 | 580.18 Thousand USD | 37.06% |
| 2007 Q2 | 1.06 Million USD | 84.08% |
| 2007 Q4 | 280.77 Thousand USD | -40.47% |
| 2007 Q3 | 471.63 Thousand USD | -55.84% |
| 2007 FY | 2.4 Million USD | -10.53% |
| 2006 Q2 | 712.81 Thousand USD | 3.29% |
| 2006 Q3 | 856.95 Thousand USD | 20.22% |
| 2006 Q4 | 423.3 Thousand USD | -50.6% |
| 2006 FY | 2.68 Million USD | 560.55% |
| 2006 Q1 | 690.13 Thousand USD | 161.51% |
| 2005 FY | 406.2 Thousand USD | -73.13% |
| 2005 Q3 | 171.62 Thousand USD | 242.03% |
| 2005 Q4 | 263.9 Thousand USD | 53.77% |
| 2005 Q1 | 89.02 Thousand USD | -74.18% |
| 2005 Q2 | -120.83 Thousand USD | -235.74% |
| 2004 FY | 1.51 Million USD | 121.92% |
| 2004 Q1 | 239.83 Thousand USD | 191.19% |
| 2004 Q2 | 404.54 Thousand USD | 68.68% |
| 2004 Q3 | 522.81 Thousand USD | 29.23% |
| 2004 Q4 | 344.8 Thousand USD | -34.05% |
| 2003 FY | 681.31 Thousand USD | 232.35% |
| 2003 Q2 | 463.21 Thousand USD | 718.18% |
| 2003 Q1 | 56.61 Thousand USD | 116.62% |
| 2003 Q4 | -263 Thousand USD | -162.09% |
| 2003 Q3 | 423.62 Thousand USD | -8.55% |
| 2002 Q2 | -55.14 Thousand USD | -1.27% |
| 2002 FY | -514.76 Thousand USD | -165.63% |
| 2002 Q4 | -340.61 Thousand USD | -427.68% |
| 2002 Q3 | -64.54 Thousand USD | -17.04% |
| 2002 Q1 | -54.45 Thousand USD | -119.21% |
| 2001 Q2 | 102.58 Thousand USD | 19.5% |
| 2001 Q4 | 283.54 Thousand USD | -9.21% |
| 2001 Q3 | 312.3 Thousand USD | 204.43% |
| 2001 Q1 | 85.85 Thousand USD | 145.37% |
| 2001 FY | 784.29 Thousand USD | 56.66% |
| 2000 Q1 | 56.83 Thousand USD | 0.0% |
| 2000 Q2 | 259.14 Thousand USD | 355.95% |
| 2000 Q3 | 149.66 Thousand USD | -42.25% |
| 2000 FY | 500.62 Thousand USD | 122.92% |
| 2000 Q4 | 34.98 Thousand USD | -76.62% |
| 1999 FY | -2.18 Million USD | -118.81% |
| 1998 FY | -998.04 Thousand USD | -1106.19% |
| 1997 FY | 99.19 Thousand USD | -75.65% |
| 1996 FY | 407.3 Thousand USD | 364.31% |
| 1995 FY | -154.1 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -81.66 Million USD | 77.085% |
| Cerus Corporation | -37.48 Million USD | 50.084% |
| OrthoPediatrics Corp. | -20.97 Million USD | 10.78% |
| PetVivo Holdings, Inc. | -10.95 Million USD | -70.812% |
| Talis Biomedical Corporation | -62 Million USD | 69.821% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | -37.768% |
| Inogen, Inc. | -102.44 Million USD | 81.734% |
| Spectral AI, Inc. | -20.85 Million USD | 10.267% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 69.21% |
| CVRx, Inc. | -41.19 Million USD | 54.579% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 3023.011% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | -111.446% |
| Orthofix Medical Inc. | -151.39 Million USD | 87.64% |
| Venus Concept Inc. | -37.25 Million USD | 49.764% |
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 69.631% |
| Bioventus Inc. | -156.23 Million USD | 88.022% |
| BrainsWay Ltd. | -4.19 Million USD | -345.866% |
| Envoy Medical, Inc. | -29.9 Million USD | 37.431% |
| electroCore, Inc. | -18.83 Million USD | 0.642% |
| IceCure Medical Ltd | -14.65 Million USD | -27.716% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 64.469% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | -36.142% |
| MaxCyte, Inc. | -37.92 Million USD | 50.655% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | -57.789% |
| Nexalin Technology, Inc. | -4.64 Million USD | -302.542% |
| PAVmed Inc | -64.17 Million USD | 70.841% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 64.334% |
| RxSight, Inc. | -48.6 Million USD | 61.502% |
| Sight Sciences, Inc. | -55.54 Million USD | 66.311% |
| SI-BONE, Inc. | -43.33 Million USD | 56.819% |
| TELA Bio, Inc. | -46.66 Million USD | 59.898% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 68.303% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 62.217% |
| LivaNova PLC | 17.54 Million USD | 206.651% |
| 908 Devices Inc. | -36.39 Million USD | 48.589% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 89.974% |
| Nemaura Medical Inc. | -14.14 Million USD | -32.306% |
| NeuroPace, Inc. | -32.95 Million USD | 43.218% |
| LENSAR, Inc. | -14.38 Million USD | -30.105% |
| Cutera, Inc. | -162.83 Million USD | 88.508% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | -72.789% |
| BioSig Technologies, Inc. | -29.04 Million USD | 35.564% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 77.363% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | 15.284% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 127.624% |
| Axonics, Inc. | -6.08 Million USD | -207.375% |
| Outset Medical, Inc. | -172.79 Million USD | 89.171% |
| IRIDEX Corporation | -9.57 Million USD | -95.538% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 82.329% |
| IRadimed Corporation | 17.19 Million USD | 208.842% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -126.989% |
| INVO Bioscience, Inc. | -8.03 Million USD | -132.905% |
| Telesis Bio, Inc. | -47.72 Million USD | 60.789% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 282.691% |
| Varex Imaging Corporation | -47.7 Million USD | 60.769% |
| Quipt Home Medical Corp. | -2.78 Million USD | -572.162% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -65.807% |
| Pulmonx Corporation | -60.84 Million USD | 69.244% |
| Dynatronics Corporation | -2.69 Million USD | -593.66% |
| Modular Medical, Inc. | -17.47 Million USD | -7.115% |
| ReShape Lifesciences Inc. | -11.38 Million USD | -64.337% |
| Semler Scientific, Inc. | 20.58 Million USD | 190.915% |
| InMode Ltd. | 197.91 Million USD | 109.455% |
| Bruker Corporation | 427.2 Million USD | 104.38% |
| Cytosorbents Corporation | -28.5 Million USD | 34.357% |
| DexCom, Inc. | 541.5 Million USD | 103.456% |
| Align Technology, Inc. | 445.05 Million USD | 104.205% |
| Viveve Medical, Inc. | -22.02 Million USD | 15.045% |
| ZimVie Inc. | -393.28 Million USD | 95.242% |
| Movano Inc. | -29.28 Million USD | 36.096% |
| Cytek Biosciences, Inc. | -12.14 Million USD | -54.042% |
| Nexalin Technology, Inc. | -4.64 Million USD | -302.542% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 3023.011% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 91.594% |
| Profound Medical Corp. | -28.56 Million USD | 34.499% |
| Insulet Corporation | 206.3 Million USD | 109.071% |
| enVVeno Medical Corporation | -23.51 Million USD | 20.424% |
| Surmodics, Inc. | -11.54 Million USD | -62.13% |
| iCAD, Inc. | -4.84 Million USD | -286.074% |
| Nuwellis, Inc. | -20.2 Million USD | 7.403% |
| Biotricity, Inc. | -14.09 Million USD | -32.77% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 84.836% |
| Aethlon Medical, Inc. | -12.2 Million USD | -53.283% |
| InspireMD, Inc. | -19.91 Million USD | 6.04% |
| PAVmed Inc. | -64.17 Million USD | 70.841% |
| BIOLASE, Inc. | -20.63 Million USD | 9.301% |
| Beyond Air, Inc. | -60.24 Million USD | 68.937% |
| FONAR Corporation | 10.56 Million USD | 277.082% |
| AxoGen, Inc. | -21.71 Million USD | 13.829% |
| Vivani Medical, Inc. | -25.65 Million USD | 27.051% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 165.625% |
| Inari Medical, Inc. | -1.63 Million USD | -1043.826% |
| UFP Technologies, Inc. | 44.92 Million USD | 141.655% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | -264.61% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | -183.307% |
| Tenon Medical, Inc. | -15.58 Million USD | -20.101% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | -21.308% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 47.038% |
| AdaptHealth Corp. | -678.89 Million USD | 97.244% |
| Sintx Technologies, Inc. | -8.25 Million USD | -126.577% |
| NanoVibronix, Inc. | -3.71 Million USD | -404.258% |
| Quanterix Corporation | -32.33 Million USD | 42.126% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -65.807% |
| Sensus Healthcare, Inc. | 485 Thousand USD | 3958.351% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 93.899% |
| TransMedics Group, Inc. | -25.02 Million USD | 25.232% |
| ReWalk Robotics Ltd. | -22.13 Million USD | 15.452% |
| NeuroMetrix, Inc. | -6.52 Million USD | -186.592% |
| Hyperfine, Inc. | -44.23 Million USD | 57.699% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 76.162% |
| Biomerica, Inc. | -5.97 Million USD | -213.031% |
| Bone Biologics Corporation | -8.94 Million USD | -109.113% |
| AVITA Medical, Inc. | -39.16 Million USD | 52.224% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | -87.997% |
| Silk Road Medical, Inc | -55.74 Million USD | 66.43% |